Regeneron Pharmaceuticals, Inc. (REGN)
Growth
Revenue 5Y26.33%
Revenue 3Y33.92%
EPS 5Y54.40%
EPS 3Y49.07%
Dividend 5Y-
Dividend 3Y-
Capital Efficiency
ROIC25.13%
ROE26.58%
ROA19.40%
ROTA19.40%
Capital Structure
Market Cap80.72B
EV79.93B
Cash3.49B
Current Ratio5.36
Debt/Equity0.23
Net Debt/EBITDA-0.12
REGN
Income Statement
Select a metric from the list below to chart it
Dec '90
Dec '96
Dec '02
Dec '08
Dec '14
Dec '20
| Income Statement | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,104.7 | 2,819.6 | 4,103.7 | 4,860.4 | 5,872.2 | 6,710.8 | 7,863.4 | 8,497.1 | 16,071.7 | 13,710.2 | |
| Revenue % Chg. | 52.7% | 34.0% | 45.5% | 18.4% | 20.8% | 14.3% | 17.2% | 8.1% | 89.1% | 1.2% | |
| Cost of Revenue | 155.4 | 205.0 | 392.7 | 299.7 | 397.1 | 434.1 | 782.2 | 1,119.9 | 2,437.5 | 2,002.4 | |
| Cost of Revenue % Chg. | 84.0% | 32.0% | 91.5% | -23.7% | 32.5% | 9.3% | 80.2% | 43.2% | 117.7% | 10.8% | |
| Gross Profit | 1,949.4 | 2,614.5 | 3,711.0 | 4,560.7 | 5,475.2 | 6,276.7 | 7,081.2 | 7,377.2 | 13,634.2 | 11,707.8 | |
| Gross Profit % Chg. | 50.6% | 34.1% | 41.9% | 22.9% | 20.1% | 14.6% | 12.8% | 4.2% | 84.8% | -0.2% | |
| Gross Profit Margin | 92.6% | 92.7% | 90.4% | 93.8% | 93.2% | 93.5% | 90.1% | 86.8% | 84.8% | 85.4% | |
| Gross Profit Margin % Chg. | -1.3% | 0.1% | -2.5% | 3.8% | -0.6% | 0.3% | -3.7% | -3.6% | -2.3% | -1.4% | |
| R&D Expenses | 859.9 | 1,271.4 | 1,620.6 | 2,052.3 | 2,075.1 | 2,186.1 | 3,036.6 | 2,735.0 | 2,908.1 | 3,335.0 | |
| R&D Expenses % Chg. | 37.5% | 47.8% | 27.5% | 26.6% | 1.1% | 5.3% | 38.9% | -9.9% | 6.3% | 16.3% | |
| Selling, General, & Admin Expenses | 329.4 | 504.8 | 838.5 | 1,177.7 | 1,320.4 | 1,556.2 | 1,834.8 | 1,346.0 | 1,824.9 | 2,015.0 | |
| Selling, General, & Admin Expenses % Chg. | 56.3% | 53.2% | 66.1% | 40.4% | 12.1% | 17.9% | 17.9% | -26.6% | 35.6% | 28.4% | |
| Other Expenses | - | - | - | - | - | - | - | -280.4 | -45.6 | -99.1 | |
| Other Expenses % Chg. | - | - | - | - | - | - | - | - | 83.7% | 43.4% | |
| Operating Income | 760.0 | 838.4 | 1,251.9 | 1,330.7 | 2,079.6 | 2,534.4 | 2,209.8 | 3,576.6 | 8,946.8 | 6,231.8 | |
| Operating Income % Chg. | 66.0% | 10.3% | 49.3% | 6.3% | 56.3% | 21.9% | -12.8% | 61.9% | 150.1% | -16.6% | |
| Operating Income Margin | 36.1% | 29.7% | 30.5% | 27.4% | 35.4% | 37.8% | 28.1% | 42.1% | 55.7% | 45.5% | |
| Operating Income Margin % Chg. | 8.8% | -17.7% | 2.6% | -10.3% | 29.3% | 6.6% | -25.6% | 49.8% | 32.3% | -17.6% | |
| Total Other Income/Expenses Net | -46.7 | -62.7 | -26.8 | -0.9 | -1.1 | 19.1 | 219.3 | 233.8 | 379.0 | -194.3 | |
| Total Other Income/Expenses Net % Chg. | 7.8% | 34.3% | 57.2% | 96.5% | 16.6% | - | 1048.2% | 6.6% | 62.1% | - | |
| Income Before Tax | 713.4 | 775.7 | 1,225.1 | 1,329.8 | 2,078.5 | 2,553.5 | 2,429.1 | 3,810.4 | 9,325.8 | 6,037.5 | |
| Income Before Tax % Chg. | 72.1% | 8.7% | 57.9% | 8.5% | 56.3% | 22.9% | -4.9% | 56.9% | 144.7% | -25.0% | |
| Income Before Tax Margin | 33.9% | 27.5% | 29.9% | 27.4% | 35.4% | 38.1% | 30.9% | 44.8% | 58.0% | 44.0% | |
| Income Before Tax Margin % Chg. | 12.7% | -18.8% | 8.5% | -8.4% | 29.4% | 7.5% | -18.8% | 45.2% | 29.4% | -25.9% | |
| Income Tax Expense | 289.0 | 427.7 | 589.0 | 434.3 | 880.0 | 109.1 | 313.3 | 297.2 | 1,250.5 | 667.2 | |
| Income Tax Expense % Chg. | - | 48.0% | 37.7% | -26.3% | 102.6% | -87.6% | 187.2% | -5.1% | 320.8% | -36.5% | |
| Net Income | 424.4 | 348.1 | 636.1 | 895.5 | 1,198.5 | 2,444.4 | 2,115.8 | 3,513.2 | 8,075.3 | 5,370.3 | |
| Net Income % Chg. | -43.4% | -18.0% | 82.7% | 40.8% | 33.8% | 104.0% | -13.4% | 66.0% | 129.9% | -23.2% | |
| Net Income Margin | 20.2% | 12.3% | 15.5% | 18.4% | 20.4% | 36.4% | 26.9% | 41.3% | 50.2% | 39.2% | |
| Net Income Margin % Chg. | -63.0% | -38.8% | 25.6% | 18.9% | 10.8% | 78.5% | -26.1% | 53.7% | 21.5% | -24.2% | |
| Weighted Avg. Shares Out | 97.9 | 100.6 | 103.1 | 104.7 | 106.3 | 107.9 | 109.2 | 107.6 | 107.6 | 107.0 | |
| Weighted Avg. Shares Out % Chg. | 3.4% | 2.8% | 2.4% | 1.6% | 1.5% | 1.5% | 1.2% | -1.5% | - | 1.4% | |
| EPS | 4.3 | 3.5 | 6.2 | 8.6 | 11.3 | 22.7 | 19.4 | 32.7 | 76.4 | 50.3 | |
| EPS % Chg. | -45.3% | -20.1% | 78.3% | 38.6% | 31.8% | 101.0% | -14.4% | 68.5% | 134.0% | -24.2% | |
| Weighted Avg. Shares Out Dil | 111.3 | 113.4 | 115.2 | 116.4 | 116.0 | 114.8 | 114.6 | 115.1 | 115.1 | 113.3 | |
| Weighted Avg. Shares Out Dil % Chg. | -3.5% | 1.9% | 1.6% | 1.0% | -0.4% | -1.0% | -0.2% | 0.4% | - | 1.3% | |
| EPS Diluted | 3.8 | 3.1 | 5.5 | 7.7 | 10.3 | 21.3 | 18.5 | 30.5 | 72.0 | 47.4 | |
| EPS Diluted % Chg. | -43.6% | -19.4% | 79.8% | 39.5% | 34.3% | 105.9% | -13.3% | 65.3% | 135.8% | -24.3% | |
| Interest Expense | 46.4 | 37.4 | 14.2 | 7.2 | 25.1 | 28.2 | 30.2 | 56.9 | 57.3 | 56.1 | |
| Interest Expense % Chg. | 2.5% | -19.5% | -61.9% | -49.5% | 249.1% | 12.3% | 7.1% | 88.4% | 0.7% | -3.3% | |
| EBIT | 666.9 | 738.4 | 1,210.9 | 1,322.6 | 2,053.4 | 2,525.3 | 2,398.9 | 3,753.5 | 9,268.5 | 5,981.4 | |
| EBIT % Chg. | 80.7% | 10.7% | 64.0% | 9.2% | 55.3% | 23.0% | -5.0% | 56.5% | 146.9% | -25.1% | |
| EBIT Margin | 31.7% | 26.2% | 29.5% | 27.2% | 35.0% | 37.6% | 30.5% | 44.2% | 57.7% | 43.6% | |
| EBIT Margin % Chg. | 18.3% | -17.4% | 12.7% | -7.8% | 28.5% | 7.6% | -18.9% | 44.8% | 30.6% | -26.0% | |
| Depreciation & Amortization | 41.2 | 52.7 | 74.9 | 104.7 | 145.5 | 148.2 | 210.3 | 235.9 | 286.2 | 315.8 | |
| Depreciation & Amortization % Chg. | 11.5% | 27.9% | 42.2% | 39.8% | 38.9% | 1.9% | 41.9% | 12.2% | 21.3% | 15.5% | |
| EBITDA | 708.1 | 791.1 | 1,285.8 | 1,427.4 | 2,198.9 | 2,673.5 | 2,609.2 | 3,989.4 | 9,554.7 | 6,297.2 | |
| EBITDA % Chg. | 74.4% | 11.7% | 62.5% | 11.0% | 54.1% | 21.6% | -2.4% | 52.9% | 139.5% | -23.8% | |
| EBITDA Margin | 33.6% | 28.1% | 31.3% | 29.4% | 37.4% | 39.8% | 33.2% | 47.0% | 59.5% | 45.9% | |
| EBITDA Margin % Chg. | 14.2% | -16.6% | 11.7% | -6.3% | 27.5% | 6.4% | -16.7% | 41.5% | 26.6% | -24.7% |